109 Participants Needed

I-CARE Program for Mental Health Disorders

(I-CARE Trial)

Recruiting at 1 trial location
SC
Overseen ByStephanie C. Acquilano, MA
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Dartmouth-Hitchcock Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a program called I-CARE (Improving Care, Accelerating Recovery & Education), designed to assist children in the hospital awaiting mental health treatment. It aims to determine if a series of videos with workbook activities can reduce emotional distress and suicidal thoughts. The trial will also evaluate whether patients and hospital staff find the program helpful. Children who have visited the emergency department for suicidal thoughts or attempts and speak English are suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to contribute to innovative mental health solutions for young patients.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that the I-CARE program is safe for children?

Research has shown that the I-CARE program is safe and easy to use. In past studies, both young patients and healthcare staff found I-CARE practical and well-received, indicating that people generally like the program and can use it without issues.

No major reports of negative side effects have emerged. The program mainly involves watching videos and completing workbook activities, which are low-risk and easy to manage. Since I-CARE does not involve medication or physical procedures, the chance of negative reactions is very low.

Overall, the program is designed to teach useful skills safely. For those considering joining a clinical trial for I-CARE, it appears to be a comfortable and secure choice.12345

Why are researchers excited about this trial?

Researchers are excited about the I-CARE program because it introduces a fresh approach to supporting adolescents with mental health disorders during boarding. Unlike the usual care, which focuses on basic safety supervision, I-CARE delivers evidence-based psychosocial skills through an engaging format of web-based animated videos and workbook exercises. This method is facilitated by trained professionals who offer personalized attention, potentially accelerating recovery and improving mental health outcomes. The innovative use of digital content combined with one-on-one supervision makes it a standout among existing treatments, which typically do not integrate such interactive educational components.

What evidence suggests that the I-CARE program is effective for mental health disorders?

Research has shown that the I-CARE program, available to participants in this trial, helps reduce emotional distress in teenagers awaiting mental health treatment in hospitals. Studies indicate that after joining I-CARE, teens felt less stressed and more prepared to begin mental health care. This online program teaches essential social and emotional skills through videos and workbook exercises. Participants found it practical and helpful, suggesting it could be beneficial in similar situations. Overall, early findings suggest I-CARE can positively impact mental health and prepare teenagers for further treatment.12467

Who Is on the Research Team?

JK

JoAnna K Leyenaar, MD, PhD, MPH

Principal Investigator

Dartmouth Health

Are You a Good Fit for This Trial?

This trial is for English-speaking children aged 12-17 who are in a medical hospital due to suicidal thoughts or attempts, waiting for mental health treatment. They must be supervised by a safety attendant and can start the day after they're medically cleared.

Inclusion Criteria

Experiencing psychiatric boarding while awaiting transfer for inpatient psychiatric care
I am eligible the day after being admitted or cleared by a hospital.
Supervised one-on-one by a safety attendant
See 1 more

Exclusion Criteria

Admission or transfer for psychiatric care anticipated on the first day of potential enrollment
Cognitive or developmental delays that preclude program participation based on clinical team assessment
Clinical team concern for patient or staff safety based upon active behavioral concerns
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 week
1 visit (in-person)

Treatment

Participants engage with the I-CARE program, completing as many of the 7 videos and workbook activities as possible during their hospital stay.

Approximately 72 hours
Continuous engagement during hospital stay

Follow-up

Participants are monitored for changes in emotional distress and suicidal ideation post-discharge.

6 months
Follow-up assessments at 30 days, 3 months, and 6 months post-discharge

What Are the Treatments Tested in This Trial?

Interventions

  • Improving Care, Accelerating Recovery & Education (ICARE)
Trial Overview The I-CARE program, which includes videos and workbook activities aimed at reducing emotional distress and suicide risk among hospitalized youth awaiting psychiatric care, is being tested for its effectiveness and acceptability.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: I-CAREExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Improving Care, Accelerating Recovery & Education (ICARE) is already approved in United States for the following indications:

🇺🇸
Approved in United States as I-CARE for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Dartmouth-Hitchcock Medical Center

Lead Sponsor

Trials
548
Recruited
2,545,000+

University of Vermont

Collaborator

Trials
283
Recruited
3,747,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Dartmouth College

Collaborator

Trials
93
Recruited
1,415,000+

Children's Hospital of Philadelphia

Collaborator

Trials
749
Recruited
11,400,000+

University of Vermont Medical Center

Collaborator

Trials
46
Recruited
25,900+

Published Research Related to This Trial

After one year of training, 35 New Zealand practitioners found it challenging to fully implement Integrated Mental Health Care (IMHC) due to resource constraints, despite its potential for cost-effectiveness compared to traditional hospital care.
Practitioners appreciated the structured approach and psychosocial focus of IMHC, which positively influenced their views on severe mental health issues, but they suggested adaptations to better fit local needs and enhance flexibility.
Integrated mental health care: practitioners' perspectives.Allen, RE., Read, J.[2017]
A quality improvement project involving 124 psychiatric patients showed that individualized safety plans created during inpatient treatment were well-tailored, scoring an average of 32.85 out of 44 on a customization rubric.
Postdischarge, 96.1% of patients retained their safety plans, and 36.8% reported using them, with 67.9% of those users finding the plans helpful, indicating that these plans can support recovery after hospitalization.
Bridging the Gap Between Individualized Inpatient Safety Planning and Postdischarge Efficacy.Leonard, J., Chiappetta, L., Stark, S., et al.[2023]
The RECOVER model for mental health care is being tested against standard care (TAU) in a study involving 890 patients, focusing on its effectiveness in reducing healthcare costs and improving patient outcomes over 6 and 12 months.
The study will measure key outcomes such as symptom improvement, daily functioning, and quality of life, using rigorous statistical methods to ensure unbiased results, which could demonstrate the cost-effectiveness of the RECOVER model.
Study protocol for a randomised controlled trial evaluating an evidence-based, stepped and coordinated care service model for mental disorders (RECOVER).Lambert, M., Karow, A., Gallinat, J., et al.[2023]

Citations

Efficacy of the I-CARE Digital Health InterventionI-CARE is a brief, digital intervention designed for adolescents who are boarding in a medical hospital awaiting transfer to a psychiatric inpatient unit. It ...
I-CARE: Feasibility, Acceptability, and Appropriateness of a ...This pilot study describes changes in emotional distress, severity of illness, and readiness for engagement following I-CARE participation.
I-CARE: Feasibility, Acceptability, and Appropriateness of a ...I-CARE is a novel digital health intervention designed to teach evidence-based psychosocial skills to youth awaiting transfer for inpatient psychiatric care.
4.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/36870901/
I-CARE: Feasibility, Acceptability, and Appropriateness of a ...I-CARE was feasible to implement and youth reported reduced levels of distress following participation. I-CARE has the potential to teach ...
I-CAREThis pilot study describes changes in emotional distress, illness severity, and readiness to engage in mental healthcare among youth following I-CARE.
RePORT RePORTER - National Institutes of Health (NIH) |In a pilot program evaluation, I-CARE has been shown to be feasible to implement and acceptable to youth, clinicians, and their caregivers, with levels of ...
I-CARE Program for Mental Health Disorders (I-CARE Trial)The goal of this clinical trial is to test the I-CARE program in children who are in a medical hospital awaiting inpatient mental health treatment.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security